Premium
Brief Report: Pregnancy intention and opioid use disorder treatment retention in the MOTHER study
Author(s) -
Martin Caitlin E.,
Terplan Mishka,
O'Grady Kevin E.,
Jones Hendrée E.
Publication year - 2018
Publication title -
the american journal on addictions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.997
H-Index - 76
eISSN - 1521-0391
pISSN - 1055-0496
DOI - 10.1111/ajad.12735
Subject(s) - opioid use disorder , unintended pregnancy , pregnancy , medicine , opiate substitution treatment , opioid , psychiatry , public health , psychology , family medicine , family planning , obstetrics , clinical psychology , buprenorphine , nursing , research methodology , environmental health , population , receptor , biology , genetics
Background and Objectives Opioid use disorder (OUD) during pregnancy challenges public health. This study examines how pregnancy intention affects OUD treatment. Methods The primary exposure and outcome were pregnancy intention and treatment duration among MOTHER (Maternal Opioid Treatment: Human Experimental Research) participants ( N = 175). Results Treatment durations were longer (21.3 vs. 16.3 weeks; p = .01) among intended ( n = 29) compared to unintended ( n = 146) pregnancy participants, but this was not significant in adjusted analyses. Discussion and Conclusions Unintended pregnancies intersect with OUD and may modify one's treatment outcomes. Scientific Significance OUD treatment may be a setting to help women implement informed family planning choices. (Am J Addict 2018;27:372–374)